Health Research Alliance
Browse
- No file added yet -

IUBMB Life - 2023 - Balderas‐Villalobos - Mechanisms of adaptive hypertrophic cardiac remodeling in a large animal model of.pdf

Download (3.81 MB)
journal contribution
posted on 2023-07-24, 16:16 authored by Jaime Balderas-Villalobos, J.M.L. Medina Contreras, Christopher Lynch, Rajiv Kabadi, Janee Hayles, Rafael J. Ramirez, Alex Y. Tan, Karoly kaszala, Montserrat Samsó, Jose F. Huizar, Jose M. Eltit

 
Frequent premature ventricular contractions (PVCs) promoted eccentric cardiac hypertrophy and reduced ejection fraction (EF) in a large animal model of

PVC-induced cardiomyopathy (PVC-CM), but the molecular mechanisms and markers of this hypertrophic remodeling remain unexplored. Healthy mongrel

canines were implanted with pacemakers to deliver bigeminal PVCs (50% burden with 200–220 ms coupling interval). After 12 weeks, left ventricular (LV) free wall samples were studied from PVC-CM and Sham groups. In addition to reduced LV ejection fraction (LVEF), the PVC-CM group showed larger cardiac myocytes without evident ultrastructural alterations compared to the Sham group. Biochemical markers of pathological hypertrophy, such as storeoperated Ca2+ entry, calcineurin/NFAT pathway, β-myosin heavy chain, and skeletal type α-actin were unaltered in the PVC-CM group. In contrast, prohypertrophic and antiapoptotic pathways including ERK1/2 and AKT/mTOR were activated and/or overexpressed in the PVC-CM group, which appeared

counterbalanced by an overexpression of protein phosphatase 1 and a borderline elevation of the anti-hypertrophic factor atrial natriuretic peptide. Moreover,

the potent angiogenic and pro-hypertrophic factor VEGF-A and itsreceptor VEGFR2 were significantly elevated in the PVC-CM group. In conclusion, a molecular program is in place to keep this structural remodeling associated with frequent PVCs as an adaptive pathological hypertrophy.

History

Grant ID

836430